Analytical Data
-
Gene name
GPR172A
- Application
-
Alternative Names
GPR172A；GPR172A；PAR1；RFT3；Solute carrier family 52. riboflavin transporter. member 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HAB3
-
Expression Region
1-445aa
-
AA Sequence
MAAPTPARPVLTHLLVALFGMGSWAAVNGIWVELPVVVKELPEGWSLPSYVSVLVALGNLGLLVVTLWRRLAPGKDEQVPIRVVQVLGMVGTALLASLWHHVAPVAGQLHSVAFLALAFVLALACCASNVTFLPFLSHLPPRFLRSFFLGQGLSALLPCVLALVQGVGRLECPPAPINGTPGPPLDFLERFPASTFFWALTALLVASAAAFQGLLLLLPPPPSVPTGELGSGLQVGAPGAEEEVEESSPLQEPPSQAAGTTPGPDPKAYQLLSARSACLLGLLAATNALTNGVLPAVQSFSCLPYGRLAYHLAVVLGSAANPLACFLAMGVLCRSLAGLGGLSLLGVFCGGYLMALAVLSPCPPLVGTSAGVVLVVLSWVLCLGVFSYVKVAASSLLHGGGRPALLAAGVAIQVGSLLGAVAMFPPTSIYHVFHSRKDCADPCDS
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GPR172A is a G protein-coupled receptor (GPCR) that has garnered increasing interest in recent years due to its potential roles in various physiological and pathological processes. As a member of the GPCR family, GPR172A is involved in cell signaling pathways that regulate functions such as metabolism, immune response, and neurotransmission. Research indicates that GPR172A may play a role in modulating inflammatory responses and could be implicated in metabolic disorders and certain neurodegenerative diseases. However, the precise mechanisms underlying its functions and the specific pathways it influences remain largely unclear. The development of recombinant GPR172A protein has become a focal point in order to study its structure, function, and potential interactions with ligands or other cellular components. By producing recombinant GPR172A, researchers aim to elucidate its signaling mechanisms, assess its pharmacological properties, and explore its therapeutic potential. Given the critical roles of GPCRs in drug development, the study of GPR172A could open new avenues for targeted therapies in various diseases, addressing the growing need for novel treatment strategies. Thus, ongoing research into GPR172A and its recombinant protein forms holds promise for advancing our understanding of GPCR biology and its relevance in human health.
